Despite increased adiponectin and adiponectin receptor in CKD, our laboratory has demonstrated adiponectin post receptor resistance in muscle tissue of kidney disease patients with decreased levels of pACC and CPT-1 levels despite higher AdipoR1 and pAMPK expression [104]. The gene discussed is ADIPOQ; the disease is chronic kidney disease.